SHARE NOW
WATCH ON DEMAND – ABOVE | MEET THE PANEL
Cell and gene therapies have the capabilities to be successful for many patients worldwide – but have you thought about how to deliver them?
Global access is undoubtedly up for discussion as many individuals lack access to treatments that could potentially alter their health outcomes.
Developing a strategy for the delivery of therapies on a global scale requires understanding challenges in patient access as well as meticulous thought into all aspects of development from facility design to personnel criteria and much more.
Join us for an extraordinary opportunity to gain invaluable insights into developing global manufacturing capacity for advanced therapeutics. Our distinguished panel of industry experts will dive deep into the challenges associated with delivering life-changing therapies on a global scale, while sharing key strategies for building capacity and capability.
WHAT TO EXPECT
Part 1: The panel addresses key challenges associated with delivering advanced therapies at a global scale, including:
- Bridging the gaps with global capacity and capability – preparing the business case for becoming a world-leading cell and gene therapy center
- Operationalizing infrastructure challenges and opportunities – how to overcome and lessons from the field
- Planning for infrastructure, facility design, build, personnel considerations, equipment etc.
- Current challenges in global patient access to cell and gene therapy products
Part 2: The speakers answer audience questions with an interactive Q&A
MEET THE PANEL
Carol Houts
Chief Strategy Officer
Germfree
Boro Dropulić
Chief Executive Officer
Vector BioMed
This webinar is brought to you in partnership with Germfree.
